<VariationArchive RecordType="classified" VariationID="1691451" VariationName="NM_003482.4(KMT2D):c.15108_15110del (p.His5036_Glu5037delinsGln)" VariationType="Deletion" Accession="VCV001691451" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-17" DateCreated="2022-12-17" MostRecentSubmission="2022-12-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1683929" VariationID="1691451">
      <GeneList>
        <Gene Symbol="KMT2D" FullName="lysine methyltransferase 2D" GeneID="8085" HGNC_ID="HGNC:7133" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q13.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="49018978" stop="49060794" display_start="49018978" display_stop="49060794" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="49412757" stop="49449106" display_start="49412757" display_stop="49449106" Strand="-" />
          </Location>
          <OMIM>602113</OMIM>
          <Haploinsufficiency last_evaluated="2020-01-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2D">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-01-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2D">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003482.4(KMT2D):c.15108_15110del (p.His5036_Glu5037delinsGln)</Name>
      <CanonicalSPDI>NC_000012.12:49026855:TCAT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q13.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="49026856" stop="49026858" display_start="49026856" display_stop="49026858" variantLength="3" positionVCF="49026855" referenceAlleleVCF="CTCA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="49420639" stop="49420641" display_start="49420639" display_stop="49420641" variantLength="3" positionVCF="49420638" referenceAlleleVCF="CTCA" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003482.4" sequenceAccession="NM_003482" sequenceVersion="4" change="c.15108_15110delTGA" MANESelect="true">
            <Expression>NM_003482.4:c.15108_15110delTGA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001820" Type="inframe_indel" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.49420640_49420642del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.49420640_49420642del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.49026857_49026859del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.49026857_49026859del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027827.1" sequenceAccession="NG_027827" sequenceVersion="1" change="g.33467_33469del">
            <Expression>NG_027827.1:g.33467_33469del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003482.4" sequenceAccession="NM_003482" sequenceVersion="4" change="c.15108_15110del" MANESelect="true">
            <Expression>NM_003482.4:c.15108_15110del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003473.3" sequenceAccession="NP_003473" sequenceVersion="3" change="p.His5036_Glu5037delinsGln">
            <Expression>NP_003473.3:p.His5036_Glu5037delinsGln</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001820" Type="inframe_indel" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003482.4(KMT2D):c.15108_15110del (p.His5036_Glu5037delinsGln) AND Kabuki syndrome 1" Accession="RCV002466280" Version="1">
        <ClassifiedConditionList TraitSetID="2049">
          <ClassifiedCondition DB="MedGen" ID="CN030661">Kabuki syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-06-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-06-13" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-17" MostRecentSubmission="2022-12-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="2049" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1879" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Kabuki syndrome 1</ElementValue>
                <XRef ID="MONDO:0007843" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">KABUK1</ElementValue>
                <XRef Type="MIM" ID="147920" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Kabuki syndrome (KS) is characterized by typical facial features (long palpebral fissures with eversion of the lateral third of the lower eyelid; arched and broad eyebrows; short columella with depressed nasal tip; large, prominent, or cupped ears), minor skeletal anomalies, persistence of fetal fingertip pads, mild-to-moderate intellectual disability, and postnatal growth deficiency. Other findings may include: congenital heart defects, genitourinary anomalies, cleft lip and/or palate, gastrointestinal anomalies including anal atresia, ptosis and strabismus, and widely spaced teeth and hypodontia. Functional differences can include: increased susceptibility to infections and autoimmune disorders, seizures, endocrinologic abnormalities (including isolated premature thelarche in females), feeding problems, and hearing loss.</Attribute>
                <XRef ID="NBK62111" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21882399</ID>
                <ID Source="BookShelf">NBK62111</ID>
              </Citation>
              <XRef ID="2322" DB="Orphanet" />
              <XRef ID="CN030661" DB="MedGen" />
              <XRef ID="MONDO:0007843" DB="MONDO" />
              <XRef Type="MIM" ID="147920" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4949077" SubmissionDate="2022-06-13" DateLastUpdated="2022-12-17" DateCreated="2022-12-17">
        <ClinVarSubmissionID localKey="SUB11603248" submittedAssembly="hg19" title="SUB11603248" />
        <ClinVarAccession Accession="SCV002525858" DateUpdated="2022-12-17" DateCreated="2022-12-17" Type="SCV" Version="1" SubmitterName="Department of Medical Genetics, National Institute of Health" OrgID="505877" OrganizationCategory="laboratory" OrgAbbreviation="DGM - INH" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-13">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>We report the case of a 13- year-old Moroccan girl presenting with typic facial dysmorphy of Kabuki syndrome and psychomotor delay with mental retardation. Clinical exome sequencing identified a novel heterozygous variant: NM_003482.4(KMT2D):c.15108_15110delTGA (p.His5036_Glu5037delinsGln) in exon 49 of the KMT2D gene. This variant has not been previously reported and was not found in 138 Moroccan Clinical exomes (in-house database). It is classified as pathogenic on American College of Medical Genetics and Genomics (ACMG) according to these criteria: PM1,PM2,PM4, and PP3.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Ethnicity>Moroccan</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2D">
              <Name>lysine methyltransferase 2D</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_003482.4:exon 49</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003482.4:c.15108_15110delTGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="147920" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11603248</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4949077" TraitType="Disease" MappingType="XRef" MappingValue="147920" MappingRef="OMIM">
        <MedGen CUI="CN030661" Name="Kabuki syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

